Zebin Wang

Zebin (Sarah) Wang is an experienced professional in the field of oncology and translational sciences, currently serving as a Translational Sciences Leader at Bayer since May 2022. Prior to this role, Zebin held the position of Clinical Biomarker Director at GSK from January 2020 to May 2022. At TESARO, Inc., Zebin progressed through several roles from Senior Scientist to Senior Principal Scientist in Translational Strategy & Research between January 2016 and December 2019. Zebin began the career as a Postdoctoral Research Scientist in the Oncology iMED department at AstraZeneca from March 2013 to January 2016. Academically, Zebin holds a Ph.D. in Molecular Genetics and Biochemistry and a Master's Degree in Epidemiology and Biostatistics from the University of Illinois Chicago, as well as a Bachelor's Degree in Biological Sciences from Fudan University.